Angina pectoris is chest pain from myocardial ischemia, classically triggered by exertion (stable angina from fixed stenosis causing inadequate flow during increased demand) or at rest (vasospastic/Prinzmetal's angina from dynamic coronary narrowing). Vasospasm involves endothelial dysfunction (reduced nitric oxide), increased smooth muscle sensitivity to vasoconstrictors (serotonin, endothelin), and increased sympathetic tone. Vasospastic episodes are often episodic and time-of-day dependent, typically relieved by nitrates. Vasospasm over atherosclerotic lesions can precipitate acute MI.
Study the clinical distinction between stable and vasospastic angina through symptom pattern, EKG changes, and response to therapy. Understand nitrates' mechanism (nitric oxide donation to vasodilate vessels). Consider the role of endothelial dysfunction in vasospastic disease.
Not all angina is from atherosclerotic stenosis; vasospasm and microvascular dysfunction (coronary microvascular disease) cause angina with angiographically normal or minimal disease. Vasospasm can occur in angiographically normal vessels, making diagnosis challenging without provocation testing.
Angina is the symptom that announces a mismatch: the heart is demanding more oxygen than the coronary arteries are delivering. From your study of the cardiovascular system, you know that myocardial oxygen demand is set by heart rate, contractility, and wall stress, while supply is determined by coronary artery patency and the duration of diastole (when coronary blood flow actually occurs). Angina is the pain signal from ischemic myocardium — and the character of the symptoms tells you which side of the supply-demand equation is failing.
Stable angina is a supply-side story with a fixed constraint. A narrowed artery from atherosclerotic plaque delivers adequate flow at rest but cannot increase delivery when demand rises with exertion. The symptoms are predictable: pain on exertion, relieved within minutes by rest. Because the narrowing is anatomically fixed, the threshold is reproducible — the same amount of exercise reliably triggers symptoms. Vasospastic angina (Prinzmetal's angina) is a different mechanism: the artery narrows dynamically, transiently, and often at rest or in the early morning. No fixed plaque is required. The artery simply closes down on its own.
The mechanism of vasospasm centers on endothelial dysfunction and smooth muscle hyperreactivity. Healthy endothelium continuously releases nitric oxide (NO), which diffuses into smooth muscle cells and signals relaxation. When endothelium is dysfunctional, NO production falls. Meanwhile, circulating vasoconstrictors — serotonin released from activated platelets, endothelin from damaged endothelium, catecholamines from sympathetic activation — act on smooth muscle that is now hypersensitive to vasoconstriction. The result is sudden, reversible luminal narrowing severe enough to cause ST-segment elevation on EKG. Nitrates work by directly donating NO to smooth muscle, bypassing the damaged endothelium entirely.
The clinical danger is that vasospasm is not always self-limiting. Spasm over an existing atherosclerotic lesion can trigger plaque rupture, platelet aggregation, and complete thrombotic occlusion — an acute myocardial infarction. Even without plaque, sustained spasm can cause enough ischemia to trigger fatal arrhythmias. Understanding the spectrum — from stable angina on exertion to dynamic vasospasm at rest to acute infarction — matters because management differs: stable angina is treated with anti-atherosclerotic therapy and beta-blockers, while vasospasm requires calcium channel blockers (which directly relax smooth muscle) and nitrates. Beta-blockers are sometimes counterproductive in vasospasm because unopposed alpha-receptor stimulation can worsen arterial constriction.
No topics depend on this one yet.